Acute Kidney Injury with SARS-CoV-2 Infection in Pediatric Patients Receiving High-Dose Methotrexate Chemotherapy: A Report of Three Cases
Background. Methotrexate is renally excreted. HDMTX (high dose-methotrexate)-induced acute kidney injury (AKI) is a non-oliguric decrease in glomerular filtration rate (GFR) heralded by an acute rise in serum creatinine. Moreover, AKI is also a frequent complication of COVID-19. Among our patients t...
Main Authors: | Olga Nigro, Cristina Meazza, Elisabetta Schiavello, Veronica Biassoni, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Giovanna Sironi, Virginia Livellara, Gabriele Papagni, Maura Massimino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/10/2/331 |
Similar Items
-
Ultra Short Course Chemotherapy for Early-Stage Non-Hodgkin’s Lymphoma in Children
by: Elisabetta Schiavello, et al.
Published: (2022-08-01) -
A Delphi study to determine the epidemiology and clinical management of patients treated with HDMTX who develop methotrexate (MTX) delayed elimination in France, Germany, Italy, and the UK
by: Stefan Bielack, et al.
Published: (2024-01-01) -
Genetic polymorphisms as predictors of methotrexate toxicity: literature review
by: G. A. Radzhabova, et al.
Published: (2024-04-01) -
Chemotherapy and cognitive function: comprehensive review on methotrexate‐induced chemobrain
by: Nadine C. Sabry, et al.
Published: (2023-12-01) -
Co-Delivery of Methotrexate and Nanohydroxyapatite with Polyethylene Glycol Polymers for Chemotherapy of Osteosarcoma
by: Lingbin Ou, et al.
Published: (2023-03-01)